Statements (55)
Predicate | Object |
---|---|
gptkbp:instanceOf |
Virus
|
gptkbp:affiliatedWith |
Picornaviridae family
|
gptkbp:associated_with |
Pneumonia
Chronic obstructive pulmonary disease (COPD) Asthma exacerbations Bronchiolitis |
gptkbp:causedBy |
Common cold
|
gptkbp:clinicalTrials |
Major cause of respiratory infections
Mild to moderate illness |
gptkbp:community |
High economic burden due to healthcare costs
|
gptkbp:community_impact |
Higher in children
|
gptkbp:complications |
Sinusitis
Otitis media Worsening of chronic respiratory diseases |
gptkbp:culturalHeritage |
High genetic variability
|
gptkbp:diseaseResistance |
Global distribution
Clinical evaluation Can continue for weeks after symptoms resolve Involves immune response Occurs during illness PCR_testing |
gptkbp:duration |
7 to 10 days
|
gptkbp:environment |
Stable at low temperatures
|
gptkbp:environmentalImpact |
Epithelial cells
|
gptkbp:genus |
Enterovirus
|
gptkbp:has |
Single-stranded RNA
|
gptkbp:hosts |
Primarily humans
|
https://www.w3.org/2000/01/rdf-schema#label |
Rhinoviruses
|
gptkbp:impact |
Hydration
Rest Over-the-counter medications Symptomatic relief No specific antiviral therapy |
gptkbp:incubationPeriod |
1 to 3 days
|
gptkbp:notable_player |
No effective vaccine available
|
gptkbp:numberOfStudents |
Over 100
|
gptkbp:releaseYear |
Identified in 1956
|
gptkbp:research |
Ongoing studies for antiviral treatments
|
gptkbp:research_focus |
Vaccine development
Antiviral_drug_discovery |
gptkbp:respondsTo |
IgM_and_IgG_antibodies
|
gptkbp:safetyFeatures |
Avoiding close contact with infected individuals
Hand_hygiene |
gptkbp:seasonalActivities |
Increased incidence in colder months
More common in fall and spring |
gptkbp:symptoms |
Fatigue
Headache Cough Sneezing Sore throat Runny nose |
gptkbp:transmission |
Airborne droplets
Fomites |
gptkbp:uses |
Humans
|
gptkbp:website |
Upper respiratory tract
|